Literature DB >> 9674898

Localization of a novel gene for nonsyndromic hearing loss (DFNB17) to chromosome region 7q31.

J H Greinwald1, S Wayne, A H Chen, D A Scott, R I Zbar, M L Kraft, S Prasad, A Ramesh, P Coucke, C R Srisailapathy, M Lovett, G Van Camp, R J Smith.   

Abstract

Autosomal recessive nonsyndromic hearing loss (ARNSHL) is the most common form of hereditary hearing impairment (HHI). To date, 16 different loci have been reported, making ARNSHL an extremely heterogeneous disorder. One of these loci, DFNB4, was mapped to a 5-cM interval of 7q31 in a large Middle-Eastern Druze family. This interval also includes the gene for Pendred syndrome. We report on three new families with HHI from the Madras region of southern India that demonstrate linkage to 7q. Their pedigrees are compatible with autosomal recessive inheritance. Furthermore, the largest family identifies a novel locus (DFNB17) telomeric to the DFNB4 and Pendred intervals. A 3-cM region of homozygosity by descent between markers D7S486 and D7S2529 is present in all affected individuals in this family and generates a multipoint LOD score of 4.24. The two other families map to the previously reported DFNB4 region but have insufficient power to attain significant LOD scores. However, mutations in the Pendred syndrome gene are present in one of these families.

Entities:  

Mesh:

Year:  1998        PMID: 9674898

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Novel autosomal recessive nonsyndromic hearing impairment locus DFNB90 maps to 7p22.1-p15.3.

Authors:  Ghazanfar Ali; Kwanghyuk Lee; Paula B Andrade; Sulman Basit; Regie Lyn P Santos-Cortez; Leon Chen; Musharraf Jelani; Muhammad Ansar; Wasim Ahmad; Suzanne M Leal
Journal:  Hum Hered       Date:  2011-07-06       Impact factor: 0.444

2.  A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss.

Authors:  Ghulam Mujtaba; Julie M Schultz; Ayesha Imtiaz; Robert J Morell; Thomas B Friedman; Sadaf Naz
Journal:  J Med Genet       Date:  2015-05-04       Impact factor: 6.318

3.  Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss.

Authors:  Hashem Shahin; Tom Walsh; Tama Sobe; Judeh Abu Sa'ed; Amal Abu Rayan; Eric D Lynch; Ming K Lee; Karen B Avraham; Mary-Claire King; Moein Kanaan
Journal:  Am J Hum Genet       Date:  2005-11-21       Impact factor: 11.025

4.  TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI.

Authors:  Arindam Chaudhury; George S Hussey; Partho S Ray; Ge Jin; Paul L Fox; Philip H Howe
Journal:  Nat Cell Biol       Date:  2010-02-14       Impact factor: 28.824

5.  Refining the DFNB17 interval in consanguineous Indian families.

Authors:  Yingshi Guo; Valentina Pilipenko; Lynne H Y Lim; Hongwei Dou; Liane Johnson; C R Srikumari Srisailapathy; Arabandi Ramesh; Daniel I Choo; Richard J H Smith; John H Greinwald
Journal:  Mol Biol Rep       Date:  2004-06       Impact factor: 2.316

6.  A novel KCNQ4 mutation and a private IMMP2L-DOCK4 duplication segregating with nonsyndromic hearing loss in a Brazilian family.

Authors:  Daniela T Uehara; Érika L Freitas; Leandro U Alves; Juliana F Mazzeu; Maria Tbm Auricchio; Alfredo Tabith; Mário Lr Monteiro; Carla Rosenberg; Regina C Mingroni-Netto
Journal:  Hum Genome Var       Date:  2015-10-29

7.  Genetic analysis of SLC26A4 gene (pendrin) related deafness among a cohort of assortative mating families from southern India.

Authors:  Jayasankaran Chandru; Justin Margret Jeffrey; Amritkumar Pavithra; S Paridhy Vanniya; G Nandhini Devi; Subathra Mahalingam; Natarajan Padmavathy Karthikeyen; C R Srikumari Srisailapathy
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-16       Impact factor: 2.503

8.  Prognostic significance of FAM3C in esophageal squamous cell carcinoma.

Authors:  Ying-Hui Zhu; Baozhu Zhang; Mengqing Li; Pinzhu Huang; Jian Sun; Jianhua Fu; Xin-Yuan Guan
Journal:  Diagn Pathol       Date:  2015-10-24       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.